Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rescue bacteriophage therapy for multidrug-resistant Pseudomonas aeruginosa infection
ChiCTR2500096948Phase 2Not yet recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Feb 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bacteriophages in Pseudomonal infection, sponsored by Shenzhen Third People's Hospital. Primary endpoint: Patient survival and safety. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
bacteriophages
03
Conditions
Pseudomonal infection
Beyond the preview
Go deeper on ChiCTR2500096948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096948.